183 related articles for article (PubMed ID: 32592194)
1. iRhom2 Promotes Hepatic Steatosis by Activating MAP3K7-Dependent Pathway.
Xu M; Ge C; Zhu L; Qin Y; Du C; Lou D; Li Q; Hu L; Sun Y; Dai X; Xiong M; Long T; Zhan J; Kuang Q; Li H; Yang Q; Huang P; Teng X; Feng J; Wu Y; Dong W; Wang B; Tan J
Hepatology; 2021 Apr; 73(4):1346-1364. PubMed ID: 32592194
[TBL] [Abstract][Full Text] [Related]
2. Functional loss of inactive rhomboid-like protein 2 mitigates obesity by suppressing pro-inflammatory macrophage activation-triggered adipose inflammation.
Xu M; Ge C; Qin Y; Lou D; Li Q; Feng J; Wu Y; Hu L; Wang B; Tan J
Mol Metab; 2020 Apr; 34():112-123. PubMed ID: 32180551
[TBL] [Abstract][Full Text] [Related]
3. Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.
Liu Y; Song J; Yang J; Zheng J; Yang L; Gao J; Tian S; Liu Z; Meng X; Wang JC; Dai Z; Tang YD
Hepatology; 2021 Sep; 74(3):1300-1318. PubMed ID: 33768585
[TBL] [Abstract][Full Text] [Related]
4. MLK3 promotes metabolic dysfunction induced by saturated fatty acid-enriched diet.
Gadang V; Kohli R; Myronovych A; Hui DY; Perez-Tilve D; Jaeschke A
Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E549-56. PubMed ID: 23860122
[TBL] [Abstract][Full Text] [Related]
5. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
Pan ZG; An XS
Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
[TBL] [Abstract][Full Text] [Related]
6. Dual-Specificity Phosphatase 26 Protects Against Nonalcoholic Fatty Liver Disease in Mice Through Transforming Growth Factor Beta-Activated Kinase 1 Suppression.
Ye P; Liu J; Xu W; Liu D; Ding X; Le S; Zhang H; Chen S; Chen M; Xia J
Hepatology; 2019 May; 69(5):1946-1964. PubMed ID: 30582764
[TBL] [Abstract][Full Text] [Related]
7. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
8. Loss of iRhom2 accelerates fat gain and insulin resistance in diet-induced obesity despite reduced adipose tissue inflammation.
Skurski J; Penniman CM; Geesala R; Dixit G; Pulipati P; Bhardwaj G; Meyerholz DK; Issuree PD; O'Neill BT; Maretzky T
Metabolism; 2020 May; 106():154194. PubMed ID: 32135161
[TBL] [Abstract][Full Text] [Related]
9. Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis.
Xiang M; Wang PX; Wang AB; Zhang XJ; Zhang Y; Zhang P; Mei FH; Chen MH; Li H
J Hepatol; 2016 Jun; 64(6):1365-77. PubMed ID: 26860405
[TBL] [Abstract][Full Text] [Related]
10. iRhom2 deficiency relieves TNF-α associated hepatic dyslipidemia in long-term PM2.5-exposed mice.
Ge CX; Qin YT; Lou DS; Li Q; Li YY; Wang ZM; Yang WW; Wang M; Liu N; Wang Z; Zhang PX; Tu YY; Tan J; Xu MX
Biochem Biophys Res Commun; 2017 Dec; 493(4):1402-1409. PubMed ID: 28965953
[TBL] [Abstract][Full Text] [Related]
11. Expression of Vsig4 attenuates macrophage-mediated hepatic inflammation and fibrosis in high fat diet (HFD)-induced mice.
Li Y; Sun JP; Wang J; Lu WH; Xie LY; Lv J; Li HX; Yang SF
Biochem Biophys Res Commun; 2019 Aug; 516(3):858-865. PubMed ID: 31266632
[TBL] [Abstract][Full Text] [Related]
12. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
[TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.
Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q
Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611
[TBL] [Abstract][Full Text] [Related]
14. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
[TBL] [Abstract][Full Text] [Related]
15. Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet.
Lambertucci F; Arboatti A; Sedlmeier MG; Motiño O; Alvarez ML; Ceballos MP; Villar SR; Roggero E; Monti JA; Pisani G; Quiroga AD; Martín-Sanz P; Carnovale CE; Francés DE; Ronco MT
J Nutr Biochem; 2018 Aug; 58():17-27. PubMed ID: 29860102
[TBL] [Abstract][Full Text] [Related]
16. Targeting DUSP16/TAK1 signaling alleviates hepatic dyslipidemia and inflammation in high fat diet (HFD)-challenged mice through suppressing JNK MAPK.
Wu YK; Hu LF; Lou DS; Wang BC; Tan J
Biochem Biophys Res Commun; 2020 Mar; 524(1):142-149. PubMed ID: 31982140
[TBL] [Abstract][Full Text] [Related]
17. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
18. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.
Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C
Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555
[TBL] [Abstract][Full Text] [Related]
19. Deficiency in Inactive Rhomboid Protein2 (iRhom2) Alleviates Alcoholic Liver Fibrosis by Suppressing Inflammation and Oxidative Stress.
Liu Y; Kuang Q; Dai X; Zhan M; Zhou L; Zhu L; Wang B
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887045
[TBL] [Abstract][Full Text] [Related]
20. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.
An S; Zhao LP; Shen LJ; Wang S; Zhang K; Qi Y; Zheng J; Zhang XJ; Zhu XY; Bao R; Yang L; Lu YX; She ZG; Tang YD
Hepatology; 2017 Dec; 66(6):1866-1884. PubMed ID: 28718215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
